Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.85B |
| 2 |
Tesla
TSLA
|
+$1.78B |
| 3 |
Apple
AAPL
|
+$1.57B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.49B |
| 5 |
Mastercard
MA
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.3B |
| 2 |
Phillips 66
PSX
|
+$650M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$475M |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$432M |
| 5 |
NRG Energy
NRG
|
+$387M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.59% |
| 2 | Financials | 9.21% |
| 3 | Consumer Discretionary | 7.33% |
| 4 | Healthcare | 5.59% |
| 5 | Communication Services | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Manitowoc
MTW
$753M
| $596K | ﹤0.01% |
69,346
-16,956
| -20% | -$165K |
|
3352
Certara
CERT
$1.24B
| $595K | ﹤0.01% |
60,105
+1,847
| +3% | +$22.4K |
|
3353
ClearPoint Neuro
CLPT
$470M
| $594K | ﹤0.01% |
49,916
-16,520
| -25% | -$257K |
|
|
NPKI
3354
NPK International
NPKI
$1.18B
| $592K | ﹤0.01% |
101,919
-41,888
| -29% | -$278K |
|
3355
Akebia Therapeutics
AKBA
$241M
| $592K | ﹤0.01% |
308,135
-67,360
| -18% | -$137K |
|
3356
MVB Financial
MVBF
$397M
| $592K | ﹤0.01% |
34,157
+4,586
| +16% | +$86.3K |
|
3357
abrdn Physical Gold Shares ETF
SGOL
$7.42B
| $591K | ﹤0.01% |
19,830
| – | – |
|
3358
Excelerate Energy
EE
$1.12B
| $591K | ﹤0.01% |
20,595
-9,184
| -31% | -$275K |
|
3359
Vanguard International Dividend Appreciation ETF
VIGI
$9.32B
| $591K | ﹤0.01% |
7,120
-3,400
| -32% | -$283K |
|
3360
Petco
WOOF
$817M
| $589K | ﹤0.01% |
192,998
-36,601
| -16% | -$115K |
|
3361
PACS Group
PACS
$7.12B
| $589K | ﹤0.01% |
52,369
-18,513
| -26% | -$243K |
|
|
ALX
3362
Alexander's
ALX
$1.4B
| $588K | ﹤0.01% |
2,809
-1,073
| -28% | -$217K |
|
3363
Farmers National Banc Corp
FMNB
$970M
| $586K | ﹤0.01% |
44,889
-17,803
| -28% | -$243K |
|
|
ONT
3364
Onterris Inc
ONT
$615M
| $584K | ﹤0.01% |
40,984
-16,245
| -28% | -$309K |
|
3365
Bowman Consulting
BWMN
$731M
| $584K | ﹤0.01% |
26,743
+1,846
| +7% | +$43K |
|
3366
MediaAlpha
MAX
$813M
| $583K | ﹤0.01% |
63,148
+685
| +1% | +$7.31K |
|
3367
QuidelOrtho
QDEL
$1.03B
| $583K | ﹤0.01% |
16,671
-2,028
| -11% | -$82.7K |
|
3368
Columbia Financial
CLBK
$1.22B
| $582K | ﹤0.01% |
38,814
-14,791
| -28% | -$229K |
|
3369
Heartland Express
HTLD
$979M
| $581K | ﹤0.01% |
63,063
-36,085
| -36% | -$382K |
|
3370
Unity Bancorp
UNTY
$620M
| $581K | ﹤0.01% |
14,267
-1,433
| -9% | -$64.8K |
|
3371
Eton Pharmaceutcials
ETON
$1.12B
| $580K | ﹤0.01% |
44,661
-10,225
| -19% | -$154K |
|
3372
Hyster-Yale Materials Handling
HY
$617M
| $578K | ﹤0.01% |
13,905
-5,662
| -29% | -$282K |
|
3373
SelectQuote
SLQT
$126M
| $577K | ﹤0.01% |
172,899
-55,304
| -24% | -$235K |
|
|
FNGA
3374
DELISTED
MicroSectors FANG+ Index 3X Leveraged ETNs due January 8, 2038
FNGA
| $576K | ﹤0.01% |
+1,600
| New | +$876K |
|
3375
Olema Pharmaceuticals
OLMA
$920M
| $576K | ﹤0.01% |
153,104
+38,225
| +33% | +$192K |
|
Similar funds
Barclays's Q1 2025 Portfolio in Review
As of Q1 2025, Barclays held 5,710 positions worth $353B, down 1.2% from $357B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $16.5B of net new capital in Q1 2025, opening 439 new positions and adding to 1,449 existing holdings. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.3B trimmed.
- Barclays's largest Q1 2025 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $3.85B increase.
- Barclays's biggest Q1 2025 reduction was Honeywell, cutting an estimated $1.3B.
- Barclays fully exited Smartsheet Inc. in Q1 2025, selling an estimated $45.7M.
- Barclays's ten largest holdings make up 37% of its $353B portfolio in Q1 2025.
- Barclays opened 439 new positions and closed 470 in Q1 2025.
- Barclays's portfolio value fell 1.2% quarter-over-quarter to $353B.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.